Mylan Barred From Selling Generic Oracea

By Elise Czajkowski · June 29, 2010, 5:10 PM EDT

A federal judge has approved dermatology company Galderma Laboratories Inc.'s bid for a preliminary injunction preventing Mylan Pharmaceuticals Inc. from selling a generic version of rosacea drug Oracea....

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Research Foundation of State University of New York et al v. Mylan Pharmaceuticals Inc.

Case Number

Court

Delaware

Nature of Suit

Patent

Date Filed

March 19, 2009

Recent Articles By Elise

August 31, 2010
Baxter Fined $4.4M For Bundling IV Fluid Contracts
June 30, 2010
Sanofi Settles False Patent Marking Qui Tam Suit
May 21, 2010
Abbott To Buy Piramal Generics Unit For $3.7B
May 07, 2010
TLC Vision Wins Confirmation Of Ch. 11 Plan
April 14, 2010
Ill. Patients Appeal Denied Antitrust Class Cert. Bid
March 23, 2010
Sanofi, Toshiba, Others Hit With False Marking Suits
January 22, 2010
Nelson Mullins Adds Medical Malpractice Partner
January 21, 2010
Mishcon Opens NY Office With Sheppard Mullin Attys
October 19, 2009
HIG Capital To Acquire Allion For $278M
October 02, 2009
Affymax Files $100M Mixed Securities Shelf